New patch pump aims to simplify diabetes management
NCT ID NCT07320495
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing a new automated insulin delivery system for adults with type 1 diabetes. The system uses a patch pump and a smart algorithm to adjust insulin automatically. Researchers will check if it improves blood sugar control and is safe to use in daily life. 200 participants will be followed for 24 weeks.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Insulin pump TouchCare Nano A8 with the APGO system
What this could lead to
If successful, this could provide a more convenient and effective way for people with type 1 diabetes to manage their blood sugar automatically.
What could go wrong
This is an early real-world study without a control group, so results may not prove superiority over existing systems. Device malfunctions or user errors could still cause blood sugar swings.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 1 are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
3rd Department of Internal Medicine, 1st Faculty of Medicine, Charles University, Prague, Czechia
RECRUITINGPrague, Czechia
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact